What Factors Have Led to Praxis Precision Medicines Inc (PRAX) Stock Trading -17.60% Below Its 52-Week High?
Oppenheimer has recently initiated Praxis Precision Medicines Inc (PRAX) stock to Outperform rating, as announced on August 5, 2024, according to Finviz. Earlier, on June 24, 2024, Needham had initiated the stock to Buy, setting a price target of $145. Guggenheim also initiated Buy rating with a price target of $155. Additionally, Robert W. Baird […]
How Praxis Precision Medicines Inc (PRAX) Stock converts water flow into cash flow
Needham raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “a Buy”. The rating was released on June 24, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $117. The stock was initiated by Truist, who disclosed […]
Is Praxis Precision Medicines Inc (PRAX) Stock a good value investment?
Needham raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “a Buy”. The rating was released on June 24, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $117. The stock was initiated by Truist, who disclosed […]
The high-quality value of Praxis Precision Medicines Inc (PRAX) Stock is hidden beneath the surface
Needham raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “a Buy”. The rating was released on June 24, 2024, according to finviz. The research report from Robert W. Baird has initiated the stock to Outperform, with a price target set at $117. The stock was initiated by Truist, who disclosed […]
Consensus Analyst Estimated Price Target of $139.71 for Praxis Precision Medicines Inc (NASDAQ:PRAX) Stock
Guggenheim raised the price target for the Praxis Precision Medicines Inc (NASDAQ:PRAX) stock to “a Buy”. The rating was released on June 18, 2024, according to finviz. The research report from Truist has initiated the stock to Buy, with a price target set at $10. The stock was downgraded by Wedbush, who disclosed in a […]